A Liver Disease Gets a New Name, Diagnostic Criteria A Liver Disease Gets a New Name, Diagnostic Criteria
Formerly known as nonalcoholic fatty liver disease, the condition will now be known as metabolic dysfunction-associated steatotic liver disease.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 13, 2023 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

NAFLD and T2DM Bodes Higher Risk of Liver Decompensation, Cancer
(MedPage Today) -- Patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes may be at significantly higher risk of hepatic decompensation and liver cancer, researchers reported. In a meta-analysis of six studies that included... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - July 12, 2023 Category: Endocrinology Source Type: news

CT shows NAFLD's association with visceral fat, sarcopenia
CT body composition data reveal associations between nonalcoholic fatty live...Read more on AuntMinnie.comRelated Reading: 3D liver segmentation detects fatty liver on cardiac CT CT spots patients with high-risk liver disease Can AI screen for nonalcoholic fatty liver disease? Fatty liver disease occurs with risky plaque Experts chew the fat on obesity, services for larger patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 10, 2023 Category: Radiology Source Type: news

NAFLD Gets a New Name. Will This One Stick?
(MedPage Today) -- Noting that the term "nonalcoholic fatty liver disease" (NAFLD) is stigmatizing, an international group of medical organizations proposed a name change to "metabolic dysfunction-associated steatotic liver disease" (MASLD). This... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 30, 2023 Category: Gastroenterology Source Type: news

Urinary Protein Panels to Diagnose NAFLD and Fibrosis Stages Urinary Protein Panels to Diagnose NAFLD and Fibrosis Stages
Newly proposed urine tests may be an accurate and less invasive means of identifying NAFLD and the stage of fibrosis.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 23, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

NAFLD Increases Risk for Severe Infections NAFLD Increases Risk for Severe Infections
A large cohort study using biopsy-proven cases confirms a link outside of known metabolic risk factors.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - June 20, 2023 Category: Internal Medicine Tags: Gastroenterology News Source Type: news

Lennar, RadNet And 3 Stocks To Watch Heading Into Wednesday
Wall Street expects Lennar Corporation to report quarterly earnings at $2.31 per share on revenue of $7.17 billion after the closing bell. Lennar shares gained 0.4% to $116.42 in after-hours trading. • RadNet, Inc reported the pricing of its underwritten public offering of 7,575,000 shares at…#lennarcorporation #radnetinc #rfindustriesltd #rfindustries #inventivasa #phaseii #t2d #nafld #inventiva #auroracannabisinc (Source: Reuters: Health)
Source: Reuters: Health - June 14, 2023 Category: Consumer Health News Source Type: news

The body shape that may indicate inflammation and a risk of fatty liver disease
If you are a certain body shape, you are more prone to non-alcoholic fatty liver disease, according to Dr Igor Troickis. (Source: Daily Express - Health)
Source: Daily Express - Health - June 12, 2023 Category: Consumer Health News Source Type: news

Zydus starts trial to generate data on effect of Saroglitazar Mg in NAFLD patients
Zydus Lifesciences has launched a real-world data registry trial to determine the benefits of its liver drug, Saroglitazar Magnesium, on patients with non-alcoholic fatty liver disease and associated ailments. Between 1,500 male and female NAFLD patients are expected to be enrolled in the study, with each participant expected to be traced for around 56 weeks. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 9, 2023 Category: Pharmaceuticals Source Type: news

Risk Control and Treatment in Patients With NAFLD and T2D Risk Control and Treatment in Patients With NAFLD and T2D
A better understanding of the trends in risk factor control and medication use in this population could help improve the management of these patients.Alimentary Pharmacology & Therapeutics (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 6, 2023 Category: Surgery Tags: Gastroenterology Journal Article Source Type: news

Overweight Years and Risk of NAFLD, Fibrosis and Cirrhosis Overweight Years and Risk of NAFLD, Fibrosis and Cirrhosis
A new study looks at the potential impact of a longer duration of excess body weight on the polygenic risk of NAFLD and significant fibrosis.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 1, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Higher Mortality Among Lean Patients With NAFLD Higher Mortality Among Lean Patients With NAFLD
Despite a lower incidence of cirrhosis and diabetes mellitus, and similar incidence of cancer and cardiovascular disease, this study revealed a higher mortality rate among lean patients with NAFLD.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 11, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Lower Birthweight and NAFLD: Role of Insulin Resistance Lower Birthweight and NAFLD: Role of Insulin Resistance
Does lower birthweight impact NAFLD risk, independent of childhood and adult adiposity? Are there potential metabolic mediators for this effect?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 4, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Japanese diet could help fatty liver disease - 3 foods shown to control liver fibrosis
Following a Japanese-style could help people with non-alcoholic fatty liver disease slow its progression - if the condition develops into cirrhosis, scarring , it can lead to liver failure and life-threatening complications. (Source: Daily Express - Health)
Source: Daily Express - Health - May 3, 2023 Category: Consumer Health News Source Type: news

Secondary Bile Acids Identify Mild Liver Fibrosis in NAFLD Secondary Bile Acids Identify Mild Liver Fibrosis in NAFLD
Can circulating bile acid levels be used to accurately stage liver fibrosis in NAFLD?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 2, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news